<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03083093</url>
  </required_header>
  <id_info>
    <org_study_id>G17.014</org_study_id>
    <nct_id>NCT03083093</nct_id>
  </id_info>
  <brief_title>CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients</brief_title>
  <acronym>InShapeIII</acronym>
  <official_title>Identification of CTEPH on Standard Computerised Tomography Pulmonary Angiography Performed in the Work-up of Suspected Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Leiden University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>VU University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Leiden University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators will evaluate whether more careful reading (than the current&#xD;
      standard) of routine computerised tomography pulmonary angiography (CTPA) performed in the&#xD;
      clinical work-up of suspected (pulmonary embolism (PE) will differentiate patients with acute&#xD;
      PE from those with more chronic or acute on chronic PE, which could be indicative of the&#xD;
      presence of chronic thromboembolic pulmonary hypertension (CTEPH)&quot;&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will study 50 consecutive patients diagnosed with CTEPH as well as 50&#xD;
      patients diagnosed with acute PE in whom CTEPH was ruled out 2 years after the PE diagnosis&#xD;
      by sequential echocardiography. The cases and controls will be matched based on the&#xD;
      right-to-left ventrilcle diameter ratio.&#xD;
&#xD;
      Three experienced thorax radiologists with specific expertise on acute PE and CTEPH will&#xD;
      blindly assess the index CTPAs of the study population. In addition to the binominal&#xD;
      judgement whether CTEPH signs are already present (or not), the presence of the following&#xD;
      items will be scored by all 3 readers independently:&#xD;
&#xD;
        -  Webs or bands&#xD;
&#xD;
        -  Residual thrombus attached to the vascular wall&#xD;
&#xD;
        -  Complete occlusion /retraction&#xD;
&#xD;
        -  Mosaic perfusion&#xD;
&#xD;
        -  Pulmonary infarct&#xD;
&#xD;
        -  Parenchymal bands&#xD;
&#xD;
        -  Bronchial arteries&#xD;
&#xD;
        -  Right atrial (RA) dilatation&#xD;
&#xD;
        -  Right ventricle (RV) dilatation&#xD;
&#xD;
        -  Flattening of the septum&#xD;
&#xD;
        -  Right ventricle (RV) hypertrophy&#xD;
&#xD;
        -  Dilated truncus pulmonalis&#xD;
&#xD;
        -  Cardiac signs of pulmonary hypertension (PH)&#xD;
&#xD;
        -  Further remarks (free text)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">March 1, 2018</completion_date>
  <primary_completion_date type="Actual">March 1, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To Identify the Accuracy of Routine CTPA for the Distinction of CTEPH From Acute PE.</measure>
    <time_frame>1 year</time_frame>
    <description>The sensitivity of CTPA is determined by calculating the proportion of scans that are read as &quot;positive for the CTEPH specific radiological pattern&quot; in patients with confirmed CTEPH and the specificity is determined by calculating the proportion of scans that are read as &quot;negative for the CTEPH specific radiological pattern&quot; in patients without CTEPH.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>CTEPH</condition>
  <condition>Pulmonary Embolism</condition>
  <condition>Early Diagnosis</condition>
  <arm_group>
    <arm_group_label>CTEPH patients</arm_group_label>
    <description>the initial CTPA scan will be reviewed in patients diagnosed with CTEPH after an episode of an acute PE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non CTEPH patients</arm_group_label>
    <description>the initial CTPA scan will be reviewed in patients after an episode of an acute PE in whom CTEPH was excluded</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>The initial CTPA will be reviewed</intervention_name>
    <description>The initial CTPA will be reviewed</description>
    <arm_group_label>CTEPH patients</arm_group_label>
    <arm_group_label>non CTEPH patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The CTPA scans of the following patient populations will be compared. The first group&#xD;
        consists of patients with confirmed CTEPH after a prior diagnosis of acute PE. The control&#xD;
        group consists of patients with an episode of acute PE in whom CTEPH was excluded after 2&#xD;
        years of follow-up by echocardiography. The CTPA scans of case and control patients will be&#xD;
        matched according to the right-to-left ventricule diameter ratio.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients after an acute PE diagnosed with CTEPH according to current guidelines,&#xD;
             patients after an acute PE in whom CTEPH is excluded by follow-up echocardiography&#xD;
&#xD;
          -  availability of the CTPA scan of the initial PE episode&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  CTEPH diagnosis based on other test results than a RHC&#xD;
&#xD;
          -  Patients who did not receive anticoagulation after PE diagnosis&#xD;
&#xD;
          -  Patients under the age of 18 years old&#xD;
&#xD;
          -  Patients in the control group with a follow-up duration of less than 2 years after the&#xD;
             index PE episode&#xD;
&#xD;
          -  Use of a CTPA scanner with less than 32-detector rows&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>F.A. Klok, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>LUMC department of thormbosis and hemostasis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>LUMC</name>
      <address>
        <city>Leiden</city>
        <zip>2333 ZA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Konstantinides SV. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014 Dec 1;35(45):3145-6. doi: 10.1093/eurheartj/ehu393.</citation>
    <PMID>25452462</PMID>
  </reference>
  <reference>
    <citation>Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.</citation>
    <PMID>26318161</PMID>
  </reference>
  <reference>
    <citation>Pepke-Zaba J, Delcroix M, Lang I, Mayer E, Jansa P, Ambroz D, Treacy C, D'Armini AM, Morsolini M, Snijder R, Bresser P, Torbicki A, Kristensen B, Lewczuk J, Simkova I, Barberà JA, de Perrot M, Hoeper MM, Gaine S, Speich R, Gomez-Sanchez MA, Kovacs G, Hamid AM, Jaïs X, Simonneau G. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry. Circulation. 2011 Nov 1;124(18):1973-81. doi: 10.1161/CIRCULATIONAHA.110.015008. Epub 2011 Oct 3.</citation>
    <PMID>21969018</PMID>
  </reference>
  <reference>
    <citation>Tunariu N, Gibbs SJ, Win Z, Gin-Sing W, Graham A, Gishen P, Al-Nahhas A. Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med. 2007 May;48(5):680-4.</citation>
    <PMID>17475953</PMID>
  </reference>
  <reference>
    <citation>Doğan H, de Roos A, Geleijins J, Huisman MV, Kroft LJ. The role of computed tomography in the diagnosis of acute and chronic pulmonary embolism. Diagn Interv Radiol. 2015 Jul-Aug;21(4):307-16. doi: 10.5152/dir.2015.14403. Review.</citation>
    <PMID>26133321</PMID>
  </reference>
  <reference>
    <citation>Kim NH, Delcroix M, Jenkins DP, Channick R, Dartevelle P, Jansa P, Lang I, Madani MM, Ogino H, Pengo V, Mayer E. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D92-9. doi: 10.1016/j.jacc.2013.10.024. Review.</citation>
    <PMID>24355646</PMID>
  </reference>
  <reference>
    <citation>Lang IM, Pesavento R, Bonderman D, Yuan JX. Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding. Eur Respir J. 2013 Feb;41(2):462-8. doi: 10.1183/09031936.00049312. Epub 2012 Jun 14. Review.</citation>
    <PMID>22700839</PMID>
  </reference>
  <reference>
    <citation>Lang IM, Madani M. Update on chronic thromboembolic pulmonary hypertension. Circulation. 2014 Aug 5;130(6):508-18. doi: 10.1161/CIRCULATIONAHA.114.009309. Review.</citation>
    <PMID>25092279</PMID>
  </reference>
  <reference>
    <citation>Lang IM, Simonneau G, Pepke-Zaba JW, Mayer E, Ambrož D, Blanco I, Torbicki A, Mellemkjaer S, Yaici A, Delcroix M. Factors associated with diagnosis and operability of chronic thromboembolic pulmonary hypertension. A case-control study. Thromb Haemost. 2013 Jul;110(1):83-91. doi: 10.1160/TH13-02-0097. Epub 2013 May 16.</citation>
    <PMID>23677493</PMID>
  </reference>
  <reference>
    <citation>van der Bijl N, Klok FA, Huisman MV, van Rooden JK, Mertens BJA, de Roos A, Kroft LJM. Measurement of right and left ventricular function by ECG-synchronized CT scanning in patients with acute pulmonary embolism: usefulness for predicting short-term outcome. Chest. 2011 Oct;140(4):1008-1015. doi: 10.1378/chest.10-3174. Epub 2011 Apr 7.</citation>
    <PMID>21474573</PMID>
  </reference>
  <reference>
    <citation>Klok FA, Zondag W, van Kralingen KW, van Dijk AP, Tamsma JT, Heyning FH, Vliegen HW, Huisman MV. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med. 2010 Mar 1;181(5):501-6. doi: 10.1164/rccm.200907-1141OC. Epub 2009 Dec 3.</citation>
    <PMID>19965808</PMID>
  </reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 17, 2017</study_first_posted>
  <results_first_submitted>February 6, 2021</results_first_submitted>
  <results_first_submitted_qc>February 6, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">February 25, 2021</results_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Leiden University Medical Center</investigator_affiliation>
    <investigator_full_name>Erik Klok</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>this has to be planned</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 10, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/93/NCT03083093/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>CTEPH Patients</title>
          <description>the initial CTPA scan will be reviewed in patients diagnosed with CTEPH after an episode of an acute PE</description>
        </group>
        <group group_id="P2">
          <title>Non CTEPH Patients</title>
          <description>the initial CTPA scan will be reviewed in patients after an episode of an acute PE in whom CTEPH was excluded</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>CTEPH Patients</title>
          <description>the initial CTPA scan will be reviewed in patients diagnosed with CTEPH after an episode of an acute PE</description>
        </group>
        <group group_id="B2">
          <title>Non CTEPH Patients</title>
          <description>the initial CTPA scan will be reviewed in patients after an episode of an acute PE in whom CTEPH was excluded</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" spread="15"/>
                    <measurement group_id="B2" value="56" spread="15"/>
                    <measurement group_id="B3" value="58" spread="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Netherlands</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="50"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="100"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>To Identify the Accuracy of Routine CTPA for the Distinction of CTEPH From Acute PE.</title>
        <description>The sensitivity of CTPA is determined by calculating the proportion of scans that are read as &quot;positive for the CTEPH specific radiological pattern&quot; in patients with confirmed CTEPH and the specificity is determined by calculating the proportion of scans that are read as &quot;negative for the CTEPH specific radiological pattern&quot; in patients without CTEPH.</description>
        <time_frame>1 year</time_frame>
        <group_list>
          <group group_id="O1">
            <title>CTEPH Patients</title>
            <description>the initial CTPA scan will be reviewed in patients diagnosed with CTEPH after an episode of an acute PE</description>
          </group>
          <group group_id="O2">
            <title>Non CTEPH Patients</title>
            <description>the initial CTPA scan will be reviewed in patients after an episode of an acute PE in whom CTEPH was excluded</description>
          </group>
        </group_list>
        <measure>
          <title>To Identify the Accuracy of Routine CTPA for the Distinction of CTEPH From Acute PE.</title>
          <description>The sensitivity of CTPA is determined by calculating the proportion of scans that are read as &quot;positive for the CTEPH specific radiological pattern&quot; in patients with confirmed CTEPH and the specificity is determined by calculating the proportion of scans that are read as &quot;negative for the CTEPH specific radiological pattern&quot; in patients without CTEPH.</description>
          <units>Sensitivity</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" lower_limit="55" upper_limit="82"/>
                    <measurement group_id="O2" value="70" lower_limit="55" upper_limit="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <desc>This was an observational study; no adverse outcomes occured.</desc>
      <group_list>
        <group group_id="E1">
          <title>CTEPH Patients</title>
          <description>the initial CTPA scan will be reviewed in patients diagnosed with CTEPH after an episode of an acute PE</description>
        </group>
        <group group_id="E2">
          <title>Non CTEPH Patients</title>
          <description>the initial CTPA scan will be reviewed in patients after an episode of an acute PE in whom CTEPH was excluded</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>We studied clear-cut cases of patients with CTEPH and PE patients with RV overload who did not develop CTEPH after 2 years of follow-up, whereas, in clinical practice, the presentation of CTEPH is heterogeneous and the diagnosis is often challenging, for instance, when considering other conditions that may cause PH. Moreover, the prevalence of CTEPH in the cohort was 50%, yet this number is much lower in clinical practice.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>F.A. Klok, MD PhD</name_or_title>
      <organization>LUMC</organization>
      <phone>003171 526 9111</phone>
      <email>f.a.klok@LUMC.nl</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

